埃格列净(Inn;商标名称StigalTro)是一种治疗2型糖尿病的药物。在美国,它被食品和药物管理局批准作为单一疗法和固定剂量联合使用西他列汀或二甲双胍。在欧洲,它在2018年3月被批准用于单一疗法或联合疗法。

清空选项
6342-60-5 2-Chloro-5-methylbenzoic acid
BD409506342-60-597%
¥21.001g常备现货
14131-84-1 (3aS,4S,6R,6aS)-6-((R)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-ol
BD1426414131-84-198%
¥202.0025g常备现货
714269-57-5 (2S,3R,4S,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
BD262819714269-57-595%
¥88.001g常备现货
6638-79-5 N,O-Dimethylhydroxylamine hydrochloride
BD19586638-79-598%
¥276.00500g常备现货
13096-62-3 2,3,4,6-Tetra-O-benzyl-D-glucono-1,5-lactone
BD6493113096-62-395%
¥1398.00100g常备现货
103-73-1 Ethoxybenzene
BD147438103-73-198%
¥36.00100g常备现货
109-80-8 1,3-Propanedithiol
BD54307109-80-898%
¥130.0025g常备现货
32384-65-9 2,3,4,6-Tetra-O-(trimethylsilyl)-D-glucono-delta-lactone
BD22516532384-65-995%
¥150.00100g常备现货
461432-23-5 4-Bromo-1-chloro-2-(4-ethoxybenzyl)benzene
BD107253461432-23-597%
¥61.0025g常备现货
1210344-83-4 (S)-5-Oxopyrrolidine-2-carboxylic acid compound with (1S,2S,3S,4R,5S)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol (1:1)
BD009586301210344-83-499%
¥700.00250mg常备现货
1528636-39-6 (2S,3R,4S,5S)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6,6-bis(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
BD7492191528636-39-698%
¥2230.005g
111000-76-1 (3AS,4S,6R,6aS)-6-((tert-butyldimethylsilyl)oxy)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxole-4-carbaldehyde
BD758853111000-76-197%
¥2975.001g
1233481-95-2 2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-1,3-dithiane
BD7588541233481-95-297%
¥5509.001g
1298086-15-3 2-((Benzyloxy)(4-ethoxyphenyl)methyl)-4-bromo-1-chlorobenzene
BD010993561298086-15-395%
¥6354.001g
1